Accelerate Diagnostics, Inc.
AXDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $11,698 | $12,059 | $12,752 | $11,782 |
| % Growth | -3% | -5.4% | 8.2% | – |
| Cost of Goods Sold | $8,994 | $9,509 | $9,449 | $12,163 |
| Gross Profit | $2,704 | $2,550 | $3,303 | -$381 |
| % Margin | 23.1% | 21.1% | 25.9% | -3.2% |
| R&D Expenses | $16,688 | $25,353 | $26,915 | $21,943 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $21,326 | $31,225 | $39,193 | $49,236 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$227 | -$20 |
| Operating Expenses | $38,014 | $56,578 | $66,108 | $71,179 |
| Operating Income | -$35,310 | -$54,028 | -$62,805 | -$71,560 |
| % Margin | -301.8% | -448% | -492.5% | -607.4% |
| Other Income/Exp. Net | -$14,801 | -$6,740 | $235 | -$6,097 |
| Pre-Tax Income | -$50,111 | -$60,768 | -$62,570 | -$77,657 |
| Tax Expense | -$66 | $850 | -$77 | $45 |
| Net Income | -$50,045 | -$61,618 | -$62,493 | -$77,702 |
| % Margin | -427.8% | -511% | -490.1% | -659.5% |
| EPS | -2.15 | -4.94 | -7.61 | -12.59 |
| % Growth | 56.5% | 35.1% | 39.6% | – |
| EPS Diluted | -2.15 | -4.94 | -7.61 | -12.59 |
| Weighted Avg Shares Out | 23,302 | 12,477 | 8,216 | 6,173 |
| Weighted Avg Shares Out Dil | 23,302 | 12,477 | 8,216 | 6,173 |
| Supplemental Information | – | – | – | – |
| Interest Income | $703 | $1,123 | $551 | $88 |
| Interest Expense | $13,117 | $7,743 | $3,771 | $15,545 |
| Depreciation & Amortization | $3,421 | $3,254 | $3,000 | $2,518 |
| EBITDA | -$33,573 | -$49,771 | -$55,799 | -$59,594 |
| % Margin | -287% | -412.7% | -437.6% | -505.8% |